72159-21-8 Usage
Description
N-(1-benzyl-1H-pyrazol-3-yl)-acetamide, with the molecular formula C15H15N3O, is a chemical compound belonging to the acetamide derivative class of benzyl pyrazole. It is characterized by its potential therapeutic effects and is widely utilized in research and pharmaceutical applications.
Uses
Used in Pharmaceutical Applications:
N-(1-benzyl-1H-pyrazol-3-yl)-acetamide is used as a therapeutic agent for its potential anti-inflammatory and analgesic properties. It aids in the treatment of various conditions characterized by inflammation and pain, providing relief and improving the quality of life for patients.
Used in Neurological Disorder Treatment:
In the field of neurology, N-(1-benzyl-1H-pyrazol-3-yl)-acetamide is used as a potential treatment for neurological disorders. Its role in this application is attributed to its ability to target specific pathways and mechanisms involved in the development and progression of such disorders, offering hope for more effective treatment options.
Used in Medicinal Chemistry Research:
N-(1-benzyl-1H-pyrazol-3-yl)-acetamide serves as a valuable tool in medicinal chemistry research. Its unique chemical structure and properties make it an ideal candidate for the development of new drugs and therapeutic agents, contributing to the advancement of drug discovery and innovation in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 72159-21-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,1,5 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 72159-21:
(7*7)+(6*2)+(5*1)+(4*5)+(3*9)+(2*2)+(1*1)=118
118 % 10 = 8
So 72159-21-8 is a valid CAS Registry Number.
72159-21-8Relevant articles and documents
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 00805-00806, (2017/03/21)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
